Belite Bio Adr Stock EBITDA
| BLTE Stock | USD 63.26 4.18 6.20% |
Belite Bio ADR fundamentals help investors to digest information that contributes to Belite Bio's financial success or failures. It also enables traders to predict the movement of Belite Stock. The fundamental analysis module provides a way to measure Belite Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Belite Bio stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | -31.5 M | -30 M |
Belite | EBITDA |
Belite Bio ADR Company EBITDA Analysis
Belite Bio's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Belite Bio EBITDA | (31.53 M) |
Most of Belite Bio's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Belite Bio ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Belite EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Belite Bio is extremely important. It helps to project a fair market value of Belite Stock properly, considering its historical fundamentals such as EBITDA. Since Belite Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Belite Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Belite Bio's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Belite Ebitda
Ebitda |
|
According to the company disclosure, Belite Bio ADR reported earnings before interest,tax, depreciation and amortization of (31.53 Million). This is 103.59% lower than that of the Biotechnology sector and 131.48% lower than that of the Health Care industry. The ebitda for all United States stocks is 100.81% higher than that of the company.
Belite EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Belite Bio's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Belite Bio could also be used in its relative valuation, which is a method of valuing Belite Bio by comparing valuation metrics of similar companies.Belite Bio is currently under evaluation in ebitda category among its peers.
Belite Bio ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Belite Bio's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Belite Bio's managers, analysts, and investors.Environmental | Governance | Social |
Belite Bio Institutional Holders
Institutional Holdings refers to the ownership stake in Belite Bio that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Belite Bio's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Belite Bio's value.| Shares | Jpmorgan Chase & Co | 2024-06-30 | 88.0 | Advisor Group Holdings, Inc. | 2024-06-30 | 8.0 | Marshall Wace Asset Management Ltd | 2024-06-30 | 0.0 | Armistice Capital, Llc | 2024-09-30 | 0.0 | State Street Corp | 2024-06-30 | 15.7 K | Geode Capital Management, Llc | 2024-09-30 | 6.7 K | Citadel Advisors Llc | 2024-09-30 | 6.5 K | Hrt Financial Llc | 2024-06-30 | 5.4 K | Xtx Topco Ltd | 2024-09-30 | 5.4 K | Point72 Asset Management, L.p. | 2024-09-30 | 4.8 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 2.1 K |
Belite Fundamentals
| Return On Equity | -0.4 | ||||
| Return On Asset | -0.26 | ||||
| Current Valuation | 2 B | ||||
| Shares Outstanding | 30.88 M | ||||
| Shares Owned By Insiders | 58.60 % | ||||
| Shares Owned By Institutions | 0.49 % | ||||
| Number Of Shares Shorted | 241.07 K | ||||
| Price To Book | 18.56 X | ||||
| EBITDA | (31.53 M) | ||||
| Net Income | (31.63 M) | ||||
| Cash And Equivalents | 48.7 M | ||||
| Cash Per Share | 1.96 X | ||||
| Total Debt | 886 K | ||||
| Current Ratio | 35.01 X | ||||
| Book Value Per Share | 3.66 X | ||||
| Cash Flow From Operations | (29.84 M) | ||||
| Short Ratio | 2.48 X | ||||
| Earnings Per Share | (1.10) X | ||||
| Target Price | 79.25 | ||||
| Number Of Employees | 20 | ||||
| Beta | -1.6 | ||||
| Market Capitalization | 2.08 B | ||||
| Total Asset | 94.64 M | ||||
| Retained Earnings | (71.5 M) | ||||
| Working Capital | 86.31 M | ||||
| Net Asset | 94.64 M |
About Belite Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Belite Bio ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Belite Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Belite Bio ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Belite Bio ADR is a strong investment it is important to analyze Belite Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Belite Bio's future performance. For an informed investment choice regarding Belite Stock, refer to the following important reports:Check out Belite Bio Piotroski F Score and Belite Bio Altman Z Score analysis. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Belite Bio. If investors know Belite will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Belite Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.10) | Return On Assets (0.26) | Return On Equity (0.40) |
The market value of Belite Bio ADR is measured differently than its book value, which is the value of Belite that is recorded on the company's balance sheet. Investors also form their own opinion of Belite Bio's value that differs from its market value or its book value, called intrinsic value, which is Belite Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Belite Bio's market value can be influenced by many factors that don't directly affect Belite Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Belite Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Belite Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Belite Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.